Last updated on April 18, 2014 at 13:47 EDT

Novo Nordisk Ranks 4th Among the World’s Top 20 Science Employers

September 20, 2012

BAGSVÆRD, Denmark, September 20, 2012 /PRNewswire/ –

Novo Nordisk today was ranked number 4 on the Science 2012 Top Employer list – up from
ninth place last year. The company’s ‘innovation leadership’, ‘important quality research’
and ‘respect for employees’ and ability to inspire ‘loyalty among employees’ were cited as
key drivers of this impressive global ranking.

http://photos.prnewswire.com/prnh/20120911/559804 )

“We’re proud to have jumped up to the top five in this widely-recognised ranking of
the world’s best science employers. Our excellent researchers around the world are the
main source of this company’s strong innovation. The fact that they feel respected and
take pride in working for a company that operates in a sustainable way is great to see. In
the battle to recruit the best researchers, there’s nothing more powerful than
peer-to-peer communication,” says Mads Krogsgaard Thomsen, chief science officer and
executive vice president at Novo Nordisk.

R&D professionals at Novo Nordisk comprise world-class experts in the engineering,
expression, formulation and delivery of therapeutic proteins, as well as in the
development of compounds into safe, effective and convenient treatment options for people
living with chronic conditions like diabetes, haemophilia and rheumatoid arthritis. More
than 4,000 employees work in Novo Nordisk R&D in Denmark, US, China and India.

“This positive evaluation of Novo Nordisk resonates well with my own personal
experience as a diabetes researcher in the company for the past 21 years. Our
collaborative work in multidisciplinary teams both within and outside of the company, and
our openness to explore new ideas inspire me. It gives me the confidence that I’m part of
a highly-qualified team working every day to find better treatment solutions for people
with diabetes,” says Erica Nishimura, scientific director of Diabetes Biology at Novo

In the Science 2012 survey, 4,276 employees working in the biotechnology,
biopharmaceutical, pharmaceutical and related industries were asked to rank the 20 best
employers based on 23 characteristics, including research-driven environment and financial

About the Science 2012 Top Employer survey
[http://sciencecareers.sciencemag.org/TopEmployers2012 ]

About Novo Nordisk R&D [http://www.novonordisk.com/science/default.asp ]

Video with CSO Mads Krogsgaard Thomsen on R&D Talent on Novo Nordisk
[http://video.novonordisk.com/video/4085043/talent-in-novo-nordisk ]

Videos from Novo Nordisk R&D “Working towards the next breakthrough – Meet the people
behind our treatment pipeline”
[http://novonordisk.com/science/future-treatments/default.asp ]

Broadcast standard video and photos supporting this press release: Visit our Broadcast
room and Photos on novonordisk.com – Media

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of
innovation and leadership in diabetes care. The company also has leading positions within
haemophilia care, growth hormone therapy and hormone replacement therapy. For more
information, visit novonordisk.com [http://novonordisk.com ].

        Further information:

        Media Relations Manager
        Mette Kruse Danielsen
        Tel: +45-30-79-38-83

        In North America:
        Director, Media Relations, Communications and Public Affairs
        Ken Inchausti
        Tel: +1-609-514-8316



SOURCE Novo Nordisk

Source: PR Newswire